| Fund Description |
| The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index. The Solactive Genomics Index tracks the price movements in shares of companies which are active in the field of Genomics. These companies include those involved in the following business activities: gene editing, genomic sequencing, development and testing of genetic medicine or therapies, computational genomics and genetic diagnostics or biotechnology. |
| Fund Profile |
| Fund Name |
Genomics & Biotechnology ETF |
| Fund Exchange Ticker |
GNOM |
| Fund Sponsor |
Global X |
| Fund ISIN |
US37954Y4347 |
| Net Expense Ratio |
0.50 % |
| Fund Inception Date |
5 April 2019 |
| Fund Legal Structure |
ETF (Open end fund) |
| Exchange |
NASDAQ |
| Listing Country Code |
US |
| Fund Investment Objective |
| ETF Type Specific |
Global or ExUS Equities - Industry Sector |
| Asset Class |
Equities (Stocks) |
| Index Linked |
Passive |
| Index Name |
Solactive Genomics Index |
| Index Provider |
Solactive AG |
| Currency Hedged |
No |
| Inverse / Leveraged |
Not Applicable |
| Developed / Emerging |
Developed Market Funds |
| Market Capitalization Range |
Broad Market / Multi-Cap |
| Growth Value |
Core / Blend |
| Continent |
Not Applicable |
| Key Statistics |
| Return As of Date |
17 March 2023 |
| Asset Under Management |
198.61 Million (USD) |
| 1 Month Total Return |
-9.26 % |
| Year To Date Return |
-5.53 % |
| 1 Year Total Return |
-23.15 % |
| 3 Year Annualized Total Return |
-1.63 % |
| NAV |
11.95 |
| Share Outstanding |
16,620,000 |